Loading...

Menu

Καταχωρήθηκε: Τετάρτη 11 Σεπ 2019

Is an HLA-DRB1*1454/HLA-DRB1*1401 mismatchan acceptable mismatch in 
hematopoietic stemcell transplantation?

We discussed the role of such potential mismatches. We discussed the 
G-coding and the imporance of typoing at exon 2 and 3

An abstract was presented

Oudshoorn, Machteld & Lie, John & Roelen, Dave & Verduijn, Willem & 
Claas, Frans. (2008). Is an HLA-DRB1*1454/HLA-DRB1*1401 mismatch an 
acceptable mismatch in hematopoietic stem cell transplantation?. Tissue 
Antigens. 71. 315-316.

Recently a new DRB1*1454 allele was described by Blasczyket al. 
DRB1*1454 differs from DRB1*1401 in one nucleotideat position 51 of exon 
3 resulting in a Tyr/His exchangeat position 112 of the HLA molecule. 
 From this study, theyconclude that DRB1*1454 is most likely the most 
commonDRB1*14 allele and is therefore of potential clinical relevancefor 
donor selection in stem cell transplantation. To establish theimportance 
of this new allele in our hematopoietic stem celltransplant patients, we 
retyped 34 recipient-donor pairs withDRB1*1401. DRB1*1454 was present in 
30 recipients (88%)and in 28 of the 32 donors/cord blood units (88%). 
For 2 cordblood units, not enough DNA was present for re-typing. In 
26pairs, both recipient and donor carried DRB1*1454 (81%), in 2pairs 
DRB1*1401 was present in recipient and donor (6%) andin 4 pairs an 
incompatibility for the DRB1*14 allele was found(13%). DRB1*1401 and 
1454 are found in association withDRB3*0201 and 0202 respectively. The 
MLCs performedbetween the DRB1*14 allele mismatched combinations 
werenegative or weakly positive (mean RR¼5%, range 0–14%). Inconclusion, 
the majority of the previously DRB1*1401 typedindividuals are DRB1*1454. 
The amino acid (Tyr vs. His)differences at position 112 of the DRB1*14 
allele and the DRB3difference do not result in a primary MLC response. 
The po-tential clinical relevance of the difference between DRB1*1401and 
1454 allele in stem cell transplantation remains to bedetermined but is 
likely to be of minor importance due to theabsence of cellular 
recognition

Presenter: Prof. Spyridonidis

Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Verigou

 

 

Τηλέφωνα Επικοινωνίας:

 

Γραμματεία MMMO: 2613 603506 (ασθενείς), 2613 604062 (Γραμματεία Διευθυντή) 
Fax : 2613 604066,
email (για ιατρούς): transplant@upatras.gr,
email (για ασθενείς): mmak@upatras.gr
email (για θέματα κλινικών μελετών) : gcppatras@gmail.com
Μονάδα Μεταμόσχευσης (Νοσηλεία): 2613 603 261
Γραφείο Ιατρών: 2613 604064, 2613 604065,
Εφημερεύων Ιατρός: 2610 999111 (τηλ. κέντρο ΠΓΝΠ)

 

βρείτε μας στο χάρτη

 

Login / Sitemap

 

© Copyright 2015 - 2024 Μονάδα Μεταμόσχευσης Μυελού των Οστών Πάτρας